{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:58:38Z","timestamp":1791118718552,"version":"4.1.0"},"reference-count":286,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.pcad.2004.04.006","type":"journal-article","created":{"date-parts":[[2005,2,9]],"date-time":"2005-02-09T09:14:44Z","timestamp":1107940484000},"page":"34-57","source":"Crossref","is-referenced-by-count":103,"title":["Calcium antagonists"],"prefix":"10.1016","volume":"47","author":[{"given":"Ehud","family":"Grossman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz H.","family":"Messerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2004.04.006_BIB1","doi-asserted-by":"crossref","first-page":"97S","DOI":"10.1016\/0895-7061(96)87762-4","article-title":"Clinical relevance of 24 h blood pressure control by 1,4-dihydropyridines","volume":"9","author":"Leenen","year":"1996","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0895-7061(95)00350-9","article-title":"Relevance of 24 H blood pressure profile and sympathetic activity for outcome on short- versus long-acting 1,4-dihydropyridines","volume":"9","author":"Ruzicka","year":"1996","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2004.04.006_BIB4","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(99)10327-1","article-title":"Randomised trial of old and new antihypertensive drugs in elderly patients","volume":"354","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2004.04.006_BIB5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","article-title":"Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study","volume":"356","author":"Brown","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2004.04.006_BIB6","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/jama.289.16.2073","article-title":"Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial","volume":"289","author":"Black","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2004.04.006_BIB7","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2004.04.006_BIB8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(00)02526-5","article-title":"Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension","volume":"356","author":"Hansson","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2004.04.006_BIB9","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2004.04.006_BIB10","first-page":"26","article-title":"Enhanced vasodilatation in essential hypertension by calcium channel blockade with verapamil","volume":"4","author":"Hulthen","year":"1982","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2004.04.006_BIB11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00610047","article-title":"The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man","volume":"24","author":"Millar","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/clpt.1989.30","article-title":"Calcium entry blockade and alpha-adrenergic vascular reactivity in human beings","volume":"45","author":"Pedrinelli","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pcad.2004.04.006_BIB13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0272-6386(12)80651-2","article-title":"Natriuretic effect of calcium-channel blockers in hypertensives","volume":"18","author":"Krishna","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pcad.2004.04.006_BIB14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/01.CIR.73.1.108","article-title":"Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension","volume":"73","author":"Amodeo","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB15","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1161\/01.CIR.78.6.1394","article-title":"Systemic and regional hemodynamic and humoral effects of nitrendipine in essential hypertension","volume":"78","author":"Grossman","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9149(91)90712-T","article-title":"Cardiovascular effects of isradipine in essential hypertension","volume":"68","author":"Grossman","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF00878548","article-title":"Vascular selective calcium entry blockers in the treatment of cardiovascular disorders","volume":"9","author":"Little","year":"1995","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pcad.2004.04.006_BIB18","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1161\/01.CIR.75.5.1030","article-title":"Cardiovascular effects of verapamil in patients with essential hypertension","volume":"75","author":"Schmieder","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0002-9149(83)80133-7","article-title":"Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertension","volume":"51","author":"Ventura","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB20","first-page":"243","article-title":"Comparative pharmacology of calcium antagonists","volume":"11","author":"Wilson","year":"1995","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB21","series-title":"Hypertension, pathophysiology, diagnosis and management","first-page":"2801","article-title":"Antihypertensive care with calcium antagonists","author":"Buhler","year":"1995"},{"key":"10.1016\/j.pcad.2004.04.006_BIB22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jama.1989.03430060113035","article-title":"Calcium entry blockers in the treatment of hypertension. Current status and future prospects","volume":"262","author":"Kaplan","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2004.04.006_BIB23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000187489","article-title":"Comparison of sublingual captopril, nifedipine and prazosin in hypertensive emergencies during hemodialysis","volume":"65","author":"Wu","year":"1993","journal-title":"Nephron"},{"key":"10.1016\/j.pcad.2004.04.006_BIB24","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/archinte.1992.00400200011003","article-title":"Calcium antagonists and renal protection. Current status and future perspectives","volume":"152","author":"Epstein","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB25","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/archinte.1986.00360220071015","article-title":"Management of perioperative hypertension using sublingual nifedipine. Experience in elderly patients undergoing eye surgery","volume":"146","author":"Adler","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB26","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/0002-9378(93)90035-H","article-title":"Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor","volume":"169","author":"Glock","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9343(84)80083-2","article-title":"Calcium entry blockers for the treatment of severe hypertension and hypertensive crisis","volume":"77","author":"Frishman","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/archinte.1987.00370030160031","article-title":"Symptomatic hypotension induced by nifedipine in the acute treatment of severe hypertension","volume":"147","author":"Wachter","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB29","doi-asserted-by":"crossref","first-page":"II97","DOI":"10.1161\/01.HYP.5.4_Pt_2.II97","article-title":"Factors influencing the hypotensive effects of calcium antagonists","volume":"5","author":"Erne","year":"1983","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2004.04.006_BIB30","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/archinte.1990.00040031707020","article-title":"A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks","volume":"150","author":"Saunders","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB31","first-page":"120","article-title":"Calcium antagonists in African-American patients","volume":"8","author":"Jamerson","year":"1998","journal-title":"Ethn Dis"},{"key":"10.1016\/j.pcad.2004.04.006_BIB32","doi-asserted-by":"crossref","first-page":"81H","DOI":"10.1016\/0002-9149(85)90549-1","article-title":"Age, race, blood pressure and renin","volume":"56","author":"Kiowski","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB33","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jama.1991.03470060091033","article-title":"Management of hypertensive crises","volume":"266","author":"Gifford","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2004.04.006_BIB34","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/jama.1996.03540160050032","article-title":"Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?","volume":"276","author":"Grossman","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2004.04.006_BIB35","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0895-7061(96)00034-9","article-title":"Effects of calcium entry blockers on distribution of blood volume","volume":"9","author":"Oren","year":"1996","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-122-2-199501150-00010","article-title":"Effects of antihypertensive therapy on serum lipids","volume":"122","author":"Kasiske","year":"1995","journal-title":"Ann Intern Med"},{"issue":"Suppl 4","key":"10.1016\/j.pcad.2004.04.006_BIB37","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1097\/00005344-198806124-00031","article-title":"Acute and chronic effects of dihydropyridines on triglycerides in humans","volume":"12","author":"Pasanisi","year":"1988","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB38","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1172\/JCI111776","article-title":"Hyperinsulinemia. A link between hypertension obesity and glucose intolerance","volume":"75","author":"Modan","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2004.04.006_BIB39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s001250050023","article-title":"Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with type II diabetes","volume":"43","author":"Lehto","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.pcad.2004.04.006_BIB40","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2337\/diacare.23.8.1097","article-title":"Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality","volume":"23","author":"Pyorala","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcad.2004.04.006_BIB41","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1161\/01.STR.31.12.2936","article-title":"High proinsulin levels precede first-ever stroke in a nondiabetic population","volume":"31","author":"Lindahl","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.pcad.2004.04.006_BIB42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/diacare.21.2.221","article-title":"U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population. The Bruneck Study","volume":"21","author":"Bonora","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcad.2004.04.006_BIB43","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/ajh\/5.10.775","article-title":"Antihypertensive drug therapy and insulin resistance","volume":"5","author":"Prisant","year":"1992","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/ajh\/4.3.199","article-title":"Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension","volume":"4","author":"Sheu","year":"1991","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB45","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/00004872-200308000-00022","article-title":"Metabolic outcome during 1 year in newly detected hypertensives","volume":"21","author":"Lindholm","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB46","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/bmj.326.7391.681","article-title":"Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction","volume":"326","author":"Dunder","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.pcad.2004.04.006_BIB47","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0002-9149(84)80226-X","article-title":"Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbit","volume":"54","author":"Blumlein","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB48","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/01.RES.58.2.305","article-title":"Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110","volume":"58","author":"Habib","year":"1986","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2004.04.006_BIB49","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1172\/JCI110384","article-title":"Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine","volume":"68","author":"Henry","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2004.04.006_BIB50","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/0006-2952(84)90654-3","article-title":"Low density lipoprotein-lowering and high density lipoprotein-elevating effects of nicardipine in rats","volume":"33","author":"Ohata","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB51","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0735-1097(83)80049-7","article-title":"Verapamil suppresses atherosclerosis in cholesterol-fed rabbits","volume":"1","author":"Rouleau","year":"1983","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.ATV.6.2.237","article-title":"Suppression of atherosclerosis in cholesterol-fed rabbits by diltiazem injection","volume":"6","author":"Sugano","year":"1986","journal-title":"Arteriosclerosis"},{"issue":"Suppl","key":"10.1016\/j.pcad.2004.04.006_BIB53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.0954-6820.1984.tb08676.x","article-title":"Effect of verapamil on serum lipoproteins in patients with angina pectoris","volume":"681","author":"Walldius","year":"1984","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.pcad.2004.04.006_BIB54","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/01.ATV.5.3.250","article-title":"Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits","volume":"5","author":"Willis","year":"1985","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.pcad.2004.04.006_BIB55","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/000331978403501002","article-title":"Ineffectiveness of Ca2+-antagonists nicardipine and diltiazem on experimental atherosclerosis in cholesterol-fed rabbits","volume":"35","author":"Naito","year":"1984","journal-title":"Angiology"},{"key":"10.1016\/j.pcad.2004.04.006_BIB56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/01.ATV.4.4.389","article-title":"No effect of nifedipine on atherogenesis in cholesterol-fed rabbits","volume":"4","author":"Stender","year":"1984","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.pcad.2004.04.006_BIB57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0021-9150(84)90109-6","article-title":"Does nifedipine suppress atherogenesis in WHHL rabbits?","volume":"53","author":"Van Niekerk","year":"1984","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pcad.2004.04.006_BIB58","first-page":"307","article-title":"The antiatherogenic effects of antihypertensive drugs","volume":"14","author":"Zanchetti","year":"1992","journal-title":"Clin Exp Hypertens A"},{"key":"10.1016\/j.pcad.2004.04.006_BIB59","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1161\/01.CIR.82.6.1940","article-title":"A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis","volume":"82","author":"Waters","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB60","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0140-6736(90)91121-P","article-title":"Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT)","volume":"335","author":"Lichtlen","year":"1990","journal-title":"Lancet"},{"issue":"Suppl III","key":"10.1016\/j.pcad.2004.04.006_BIB61","first-page":"428","article-title":"Prevention of restenosis by verapamil. The verapamil Angioplasty Study (VAS)","volume":"82","author":"Hoberg","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB62","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199301213280303","article-title":"A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients","volume":"328","author":"Schroeder","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB63","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.1996.03540100029024","article-title":"Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial","volume":"276","author":"Borhani","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2004.04.006_BIB64","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1007\/BF03216270","article-title":"Retardation of development and progression of coronary atherosclerosis","volume":"39","author":"Schneider","year":"1990","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB65","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/00004872-199816110-00014","article-title":"The Verapamil in Hypertension and Atherosclerosis Study (VHAS)","volume":"16","author":"Zanchetti","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB66","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.CIR.102.13.1503","article-title":"Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events","volume":"102","author":"Pitt","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB67","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0735-1097(99)00599-9","article-title":"Restenosis and clinical outcome in patients treated with amlodipine after angioplasty","volume":"35","author":"Jorgensen","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB68","series-title":"Eleventh European Meeting on Hypertension","article-title":"The European Lacidipine Study on Atherosclerosis","author":"Zanchetti","year":"2001"},{"key":"10.1016\/j.pcad.2004.04.006_BIB69","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1161\/01.CIR.103.24.2949","article-title":"Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes","volume":"103","author":"Simon","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004872-200018020-00010","article-title":"Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness","volume":"18","author":"Tang","year":"2000","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB71","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0002-9149(89)90417-7","article-title":"Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris","volume":"64","author":"Loaldi","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB72","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/00005344-199900002-00005","article-title":"Atheroprotection with amlodipine","volume":"33","author":"Tulenko","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB73","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0002-9149(97)00611-5","article-title":"Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)","volume":"80","author":"Byington","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB74","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1161\/01.CIR.0000039288.86470.DD","article-title":"Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis","volume":"106","author":"Zanchetti","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB75","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/00005344-199906000-00009","article-title":"Effect of calcium channel blocker amlodipine on the intimal-medial thickness of carotid arterial wall in type 2 diabetes","volume":"33","author":"Koshiyama","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB76","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJM199812313392703","article-title":"Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography","volume":"339","author":"Callister","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB77","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.HYP.37.6.1410","article-title":"Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics","volume":"37","author":"Motro","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2004.04.006_BIB78","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.ATV.16.3.425","article-title":"Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels","volume":"16","author":"Jukema","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB79","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0002-9149(90)90807-D","article-title":"Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed","volume":"65","author":"Cooper","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB80","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/0002-9149(88)90562-0","article-title":"Usefulness of echocardiographic left ventricular hypertrophy, ventricular tachycardia and complex ventricular arrhythmias in predicting ventricular fibrillation or sudden cardiac death in elderly patients","volume":"62","author":"Aronow","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB81","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-105-2-173","article-title":"Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men","volume":"105","author":"Casale","year":"1986","journal-title":"Ann Intern Med"},{"issue":"3A","key":"10.1016\/j.pcad.2004.04.006_BIB82","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(83)90111-0","article-title":"Prevalence and natural history of electrocardiographic left ventricular hypertrophy","volume":"75","author":"Kannel","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB83","doi-asserted-by":"crossref","first-page":"813","DOI":"10.7326\/0003-4819-72-6-813","article-title":"Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study","volume":"72","author":"Kannel","year":"1970","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB84","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-114-5-345","article-title":"Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension","volume":"114","author":"Koren","year":"1991","journal-title":"Ann Intern Med"},{"issue":"1 B","key":"10.1016\/j.pcad.2004.04.006_BIB85","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9343(88)90816-9","article-title":"Cardiac prognosis in hypertensive patients. Incidence of sudden death and ventricular arrhythmias","volume":"84","author":"Le Heuzey","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB86","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB87","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-110-2-101","article-title":"Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study","volume":"110","author":"Levy","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB88","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0002-9343(84)90430-3","article-title":"Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy","volume":"77","author":"Messerli","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB89","first-page":"85","article-title":"Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy","volume":"6","author":"Cruickshank","year":"1992","journal-title":"J Hum Hypertens"},{"issue":"10A","key":"10.1016\/j.pcad.2004.04.006_BIB90","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9149(97)00271-3","article-title":"Cardiac effects of calcium antagonists in systemic hypertension","volume":"79","author":"Michalewicz","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB91","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0002-9149(89)90285-3","article-title":"Effect of diltiazem on left ventricular mass and diastolic filling in mild to moderate hypertension","volume":"63","author":"Szlachcic","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB92","doi-asserted-by":"crossref","first-page":"44D","DOI":"10.1016\/0002-9149(86)90805-2","article-title":"Adrenergic activity and left ventricular function during treatment of essential hypertension with calcium antagonists","volume":"57","author":"Muiesan","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB93","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199005103221904","article-title":"The effects of antihypertensive therapy on left ventricular mass in elderly patients","volume":"322","author":"Schulman","year":"1990","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.pcad.2004.04.006_BIB94","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1007\/BF03216276","article-title":"Improvement in left ventricular hypertrophy and left ventricular diastolic function following verapamil therapy in mild to moderate hypertension","volume":"39","author":"Granier","year":"1990","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB95","first-page":"135","article-title":"Diltiazem-induced left ventricular mass regression in hypertensive patients","volume":"3","author":"Weiss","year":"1987","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB96","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00005344-199008000-00017","article-title":"ECG-gated cardiac scan and echocardiographic assessments of left ventricular hypertrophy","volume":"16","author":"Senda","year":"1990","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB97","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.CIR.95.8.2007","article-title":"Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension","volume":"95","author":"Gottdiener","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB98","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00005344-199512000-00020","article-title":"Comparative effects of diltiazem and lisinopril on left ventricular structure and filling in mild-to-moderate hypertension","volume":"26","author":"van Leeuwen","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB99","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9149(96)90396-3","article-title":"Comparison of the effects of amlodipine and diltiazem on 24-hour blood pressure, plasma catecholamines, and left ventricular mass","volume":"78","author":"Leenen","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB100","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/BF00556886","article-title":"Changes in left ventricular mass during a double-blind study with chlorthalidone and slow-release nifedipine","volume":"27","author":"Ferrara","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB101","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1097\/00005344-199117002-00044","article-title":"Effect of nifedipine GITS on left ventricular mass and diastolic function in severe hypertension","volume":"17","author":"Phillips","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB102","first-page":"231","article-title":"[Evaluation of regression of left ventricular hypertrophy after antihypertensive therapy. Comparative echo-Doppler study of ace inhibitors and calcium antagonists]. Italian","volume":"41","author":"Totteri","year":"1993","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB103","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/clc.4960171110","article-title":"Regression of left ventricular hypertrophy with long-term treatment of nifedipine in systemic hypertension","volume":"17","author":"Yamakado","year":"1994","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00877754","article-title":"Comparative effects of fosinopril and nifedipine on regression of left ventricular hypertrophy in hypertensive patients","volume":"9","author":"Kirpizidis","year":"1995","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pcad.2004.04.006_BIB105","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/0895-7061(95)00117-8","article-title":"Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass","volume":"8","author":"Myers","year":"1995","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB106","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/clpt.1985.200","article-title":"Antihypertensive and cardiovascular effects of nitrendipine","volume":"38","author":"Ferrara","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pcad.2004.04.006_BIB107","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/clpt.1986.244","article-title":"Effect of the calcium channel blocker nitrendipine on left ventricular mass in patients with hypertension","volume":"40","author":"Drayer","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pcad.2004.04.006_BIB108","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0002-9149(87)90994-5","article-title":"Comparison of nitrendipine and hydrochlorothiazide for systemic hypertension","volume":"60","author":"Giles","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB109","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000176657","article-title":"Nitrendipine vs. captopril in essential hypertension","volume":"85","author":"Machnig","year":"1994","journal-title":"Cardiology"},{"key":"10.1016\/j.pcad.2004.04.006_BIB110","first-page":"644","article-title":"[Echocardiographic analysis of anatomical and functional changes in the left heart ventricle during antihypertensive treatment with nicardipine]","volume":"18","author":"Costantino","year":"1988","journal-title":"G Ital Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB111","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/0002-9149(90)91054-A","article-title":"Effects of nicardipine on left ventricular dimensions and hemodynamics in systemic hypertension","volume":"65","author":"Gokce","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB112","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/j.1552-4604.1994.tb03997.x","article-title":"Effects of long-term treatment with sustained-release nicardipine on left ventricular hypertrophy and function in patients with essential hypertension","volume":"34","author":"Sumimoto","year":"1994","journal-title":"J Clin Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.pcad.2004.04.006_BIB113","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000177466","article-title":"clinical experience in hypertension","volume":"88","author":"Langan","year":"1997","journal-title":"Cardiology"},{"key":"10.1016\/j.pcad.2004.04.006_BIB114","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00005344-199509000-00018","article-title":"Effect of amlodipine on left ventricular mass in the Amlodipine Cardiovascular Community Trial","volume":"26","author":"Kloner","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB115","first-page":"135","article-title":"One-year antihypertensive treatment with amlodipine","volume":"50","author":"Bignotti","year":"1995","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB116","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/j.1552-4604.1995.tb04025.x","article-title":"Effects of amlodipine on 24-hour ambulatory blood pressure profiles, electrocardiographic monitoring, and left ventricular mass and function in black patients with very severe hypertension","volume":"35","author":"Skoularigis","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB117","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ajh\/3.1.8","article-title":"The new calcium antagonist isradipine. Effect on blood pressure and the left ventricle in black hypertensive patients","volume":"3","author":"Carr","year":"1990","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB118","doi-asserted-by":"crossref","first-page":"188S","DOI":"10.1093\/ajh\/4.2.188S","article-title":"Regression of left ventricular hypertrophy in the short-term treatment of hypertension with isradipine","volume":"4","author":"Saragoca","year":"1991","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB119","doi-asserted-by":"crossref","first-page":"82S","DOI":"10.1093\/ajh\/6.3.82S","article-title":"Regression of left ventricular hypertrophy with isradipine antihypertensive therapy","volume":"6","author":"Vyssoulis","year":"1993","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB120","doi-asserted-by":"crossref","first-page":"86S","DOI":"10.1093\/ajh\/6.3.86S","article-title":"Regression of left ventricular hypertrophy with isradipine in previously untreated hypertensive patients","volume":"6","author":"Manolis","year":"1993","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB121","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00877104","article-title":"Evaluation of the effectiveness of isradipine SRO in the treatment of hypertensive patients with left ventricular hypertrophy","volume":"8","author":"Modena","year":"1994","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pcad.2004.04.006_BIB122","first-page":"312","article-title":"Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine","volume":"32","author":"Galderisi","year":"1994","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.pcad.2004.04.006_BIB123","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00005344-199511000-00010","article-title":"Ambulatory blood pressure and left ventricular changes during antihypertensive treatment","volume":"26","author":"Grandi","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB124","series-title":"Proceedings of the 4th International Symposium on calcium antagonists","article-title":"Effect of felodipine on left ventricular mass and Doppler-derived hemodynamics in patients with essential hypertension","author":"Pringle","year":"1989"},{"key":"10.1016\/j.pcad.2004.04.006_BIB125","first-page":"703","article-title":"Reversal of cardiac hypertrophy and left ventricular function with the calcium antagonist felodipine in hypertensive patients","volume":"4","author":"Cerasola","year":"1990","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB126","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2796.1992.tb00539.x","article-title":"Regression of left ventricular hypertrophy during long-term antihypertensive treatment\u2014A comparison between felodipine and the combination of felodipine and metoprolol","volume":"231","author":"Wetzchewald","year":"1992","journal-title":"J Intern Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB127","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0002-9149(92)90156-S","article-title":"Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy","volume":"69","author":"Leenen","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB128","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/08037059609078061","article-title":"The efficacy of felodipine ER on regression of left ventricular hypertrophy in patients with primary hypertension","volume":"5","author":"Nalbantgil","year":"1996","journal-title":"Blood Press"},{"key":"10.1016\/j.pcad.2004.04.006_BIB129","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.RES.50.5.678","article-title":"Effect of nitroglycerin and nifedipine on subendocardial perfusion in the presence of a flow-limiting coronary stenosis in the awake dog","volume":"50","author":"Bache","year":"1982","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2004.04.006_BIB130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","article-title":"A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension","volume":"115","author":"Klingbeil","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB131","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/cvr\/27.7.1350","article-title":"Cardiac structural remodelling after treatment of spontaneously hypertensive rats with nifedipine or nisoldipine","volume":"27","author":"Campbell","year":"1993","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pcad.2004.04.006_BIB132","first-page":"269","article-title":"Long term effects of amlodipine on organ damage, stroke and life span in stroke prone spontaneously hypertensive rats","volume":"228","author":"Suzuki","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB133","doi-asserted-by":"crossref","first-page":"24D","DOI":"10.1016\/S0002-9149(99)80488-3","article-title":"Response of hypertensive left ventricular hypertrophy and coronary microvascular disease to calcium antagonists","volume":"76","author":"Vogt","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB134","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00500899","article-title":"Inhibition of the slow inward current by nifedipine in mammalian ventricular myocardium","volume":"298","author":"Kohlhardt","year":"1977","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/cvr\/6.2.120","article-title":"Effect of verapamil on contractility, oxygen utilization, and calcium exchangeability in mammalian heart muscle","volume":"6","author":"Nayler","year":"1972","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pcad.2004.04.006_BIB136","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-93-5-682","article-title":"Intravenous verapamil for termination of re-entrant supraventricular tachycardias","volume":"93","author":"Sung","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB137","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.CIR.64.4.787","article-title":"Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy","volume":"64","author":"Bonow","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB138","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1136\/bmj.281.6251.1324","article-title":"Unpredictable response to nifedipine in severe cardiac failure","volume":"281","author":"Brooks","year":"1980","journal-title":"Br Med J"},{"key":"10.1016\/j.pcad.2004.04.006_BIB139","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0002-9149(81)90194-6","article-title":"Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease","volume":"47","author":"Chew","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB140","doi-asserted-by":"crossref","first-page":"15E","DOI":"10.1016\/0002-9149(85)91206-8","article-title":"Hemodynamic effects of nifedipine given alone and in combination with atenolol in patients with impaired left ventricular function","volume":"55","author":"de Buitleir","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB141","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0002-9149(85)91185-3","article-title":"Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure","volume":"56","author":"Elkayam","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB142","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.CIR.59.2.313","article-title":"Effects of verapamil on myocardial performance in coronary disease","volume":"59","author":"Ferlinz","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB143","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/01.CIR.67.1.101","article-title":"The acute hemodynamic effects of intravenous verapamil in coronary artery disease. Assessment by equilibrium-gated radionuclide ventriculography","volume":"67","author":"Klein","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB144","first-page":"28","article-title":"Differential effects of intravenous vs. intracoronary nifedipine on myocardial segment function in ischemic canine hearts","volume":"228","author":"Lamping","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pcad.2004.04.006_BIB145","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/01.CIR.63.3.584","article-title":"Regional wall motion from radiopaque markers after intravenous and intracoronary injections of nifedipine","volume":"63","author":"Serruys","year":"1981","journal-title":"Circulation"},{"issue":"Suppl 4","key":"10.1016\/j.pcad.2004.04.006_BIB146","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/00005344-199015004-00004","article-title":"Vascular selectivity of felodipine","volume":"15","author":"Thomas","year":"1990","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB147","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/cvr\/10.6.623","article-title":"Cardiovascular action of verapamil in the dog with particular reference to myocardial contractility and atrioventricular conduction","volume":"10","author":"Angus","year":"1976","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pcad.2004.04.006_BIB148","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-8703(75)90431-7","article-title":"Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram","volume":"90","author":"Heng","year":"1975","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2004.04.006_BIB149","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/01.CIR.62.5.996","article-title":"Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias","volume":"62","author":"Rinkenberger","year":"1980","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-7258(83)90025-6","article-title":"Clinical applications of slow channel blocking compounds","volume":"23","author":"Ellrodt","year":"1983","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pcad.2004.04.006_BIB151","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0306-3623(95)02096-9","article-title":"Modification of adrenergic reactivity in rat tail artery by dietary lipids and calcium channel antagonists","volume":"27","author":"Okopien","year":"1996","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB152","doi-asserted-by":"crossref","first-page":"70B","DOI":"10.1016\/0002-9149(87)90085-3","article-title":"Hemodynamic effects of PN 200\u2013110 (isradipine) in congestive heart failure","volume":"59","author":"Greenberg","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB153","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2004.04.006_BIB154","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2165\/00003495-200060050-00009","article-title":"Lercanidipine","volume":"60","author":"McClellan","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.pcad.2004.04.006_BIB155","doi-asserted-by":"crossref","first-page":"34A","DOI":"10.1016\/0002-9149(94)90272-0","article-title":"Hemodynamic and electrophysiologic effects of first- and second-generation calcium antagonists","volume":"73","author":"Vetrovec","year":"1994","journal-title":"Am J Cardiol"},{"issue":"Suppl A","key":"10.1016\/j.pcad.2004.04.006_BIB156","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0149-2918(97)80039-2","article-title":"Safety of calcium antagonists in patients with congestive heart failure","volume":"19","author":"Katz","year":"1997","journal-title":"Clin Ther"},{"key":"10.1016\/j.pcad.2004.04.006_BIB157","doi-asserted-by":"crossref","first-page":"2L","DOI":"10.1016\/S0002-9149(97)00843-6","article-title":"Overview of the treatment of heart failure","volume":"80","author":"Cohn","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB158","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJM199610103351504","article-title":"Effect of amlodipine on morbidity and mortality in severe chronic heart failure","volume":"335","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB159","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.CIR.96.3.856","article-title":"Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group","volume":"96","author":"Cohn","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB160","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0002-9149(84)90695-7","article-title":"Abnormal left ventricular filling","volume":"53","author":"Inouye","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB161","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1172\/JCI111844","article-title":"Direct and indirect effects of calcium entry blocking agents on isovolumic left ventricular relaxation in conscious dogs","volume":"75","author":"Walsh","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2004.04.006_BIB162","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0735-1097(86)80322-9","article-title":"Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension","volume":"8","author":"Smith","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB163","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/j.1552-4604.1995.tb04087.x","article-title":"Calcium antagonist use in congestive heart failure","volume":"35","author":"Piepho","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB164","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0002-9343(91)90186-2","article-title":"Left ventricular filling and stress response pattern in essential hypertension","volume":"91","author":"Grossman","year":"1991","journal-title":"Am J Med"},{"issue":"Suppl 3","key":"10.1016\/j.pcad.2004.04.006_BIB165","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF00877862","article-title":"ACE inhibitors and calcium antagonists in the treatment of congestive heart failure","volume":"9","author":"Hansen","year":"1995","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pcad.2004.04.006_BIB166","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/clc.4960200505","article-title":"Coronary risk factors, endothelial function, and atherosclerosis","volume":"20","author":"Vogel","year":"1997","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB167","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJM199007053230105","article-title":"Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension","volume":"323","author":"Panza","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB168","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1161\/01.CIR.81.6.1762","article-title":"Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension","volume":"81","author":"Linder","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB169","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.RES.62.2.185","article-title":"Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries","volume":"62","author":"Forstermann","year":"1988","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2004.04.006_BIB170","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/01.HYP.16.2.170","article-title":"Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension","volume":"16","author":"Dohi","year":"1990","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2004.04.006_BIB171","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/01.CIR.91.7.1981","article-title":"Aging and endothelial function in normotensive subjects and patients with essential hypertension","volume":"91","author":"Taddei","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB172","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1172\/JCI114688","article-title":"Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans","volume":"86","author":"Creager","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pcad.2004.04.006_BIB173","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/01.CIR.92.5.1094","article-title":"Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function","volume":"92","author":"Zeiher","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB174","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/01.HYP.8.4.344","article-title":"Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat","volume":"8","author":"L\u00fcscher","year":"1986","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2004.04.006_BIB175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/01.HYP.9.2.157","article-title":"Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats","volume":"9","author":"L\u00fcscher","year":"1987","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2004.04.006_BIB176","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.RES.71.4.776","article-title":"Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients","volume":"71","author":"Treasure","year":"1992","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2004.04.006_BIB177","doi-asserted-by":"crossref","first-page":"III193","DOI":"10.1161\/01.HYP.9.6_Pt_2.III193","article-title":"Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in rats with salt-induced hypertension","volume":"9","author":"L\u00fcscher","year":"1987","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2004.04.006_BIB178","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0735-1097(93)90238-V","article-title":"Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension","volume":"21","author":"Panza","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB179","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1161\/01.CIR.87.5.1468","article-title":"Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension","volume":"87","author":"Panza","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1007756026210","article-title":"Coronary and cardiac sensitivity to the vasoselective benzothiazepine-like calcium antagonist, clentiazem, in experimental heart failure","volume":"11","author":"Tanguay","year":"1997","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pcad.2004.04.006_BIB181","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0003-4975(96)01278-7","article-title":"Calcium-channel blockers preserve coronary endothelial reactivity after ischemia-reperfusion","volume":"63","author":"Dagenais","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.pcad.2004.04.006_BIB182","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.0000046488.52939.BF","article-title":"Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease","volume":"107","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB183","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.CIR.101.3.311","article-title":"Nifedipine-induced coronary vasodilation in ischemic hearts is attributable to bradykinin- and NO-dependent mechanisms in dogs","volume":"101","author":"Kitakaze","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB184","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/01.CIR.97.6.576","article-title":"Amlodipine releases nitric oxide from canine coronary microvessels","volume":"97","author":"Zhang","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB185","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1073\/pnas.84.24.9265","article-title":"Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide","volume":"84","author":"Ignarro","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pcad.2004.04.006_BIB186","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/01.CIR.93.7.1380","article-title":"Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension","volume":"93","author":"Frielingsdorf","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB187","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/01.CIR.73.6.1248","article-title":"Effects of diltiazem on regional coronary hemodynamics during atrial pacing in patients with stable exertional angina","volume":"73","author":"De Servi","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB188","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/01.CIR.68.1.124","article-title":"Mechanisms of angina relief after nifedipine","volume":"68","author":"Emanuelsson","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB189","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.CIR.69.4.801","article-title":"Effects of a calcium-entry blocker (diltiazem) on regional myocardial flow and function during exercise in conscious dogs","volume":"69","author":"Matsuzaki","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB190","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/0002-9149(82)90437-4","article-title":"Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol","volume":"50","author":"Subramanian","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB191","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0735-1097(00)00946-3","article-title":"First line drugs in chronic stable effort angina\u2014The case for newer, longer-acting calcium channel blocking agents","volume":"36","author":"Opie","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB192","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/hrt.43.6.648","article-title":"Pathogenetic mechanisms of angina pectoris","volume":"43","author":"Maseri","year":"1980","journal-title":"Br Heart J"},{"key":"10.1016\/j.pcad.2004.04.006_BIB193","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/01.CIR.70.6.917","article-title":"Dynamic mechanisms in human coronary stenosis","volume":"70","author":"Brown","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB194","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0735-1097(83)80037-0","article-title":"Angina caused by reduced vasodilator reserve of the small coronary arteries","volume":"1","author":"Cannon","year":"1983","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB195","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0002-9149(81)90160-0","article-title":"Dynamic coronary tone in precipitation, exacerbation and relief of angina pectoris","volume":"48","author":"Epstein","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB196","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/0002-8703(83)90081-9","article-title":"Efficacy of nifedipine therapy in patients with refractory angina pectoris","volume":"106","author":"Stone","year":"1983","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2004.04.006_BIB197","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/jama.1985.03350320055016","article-title":"Nifedipine-induced hypotension and myocardial ischemia in refractory angina pectoris","volume":"253","author":"Boden","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2004.04.006_BIB198","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0002-9149(84)90458-2","article-title":"Paradoxical angina after nifedipine","volume":"53","author":"Schanzenbacher","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB199","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0002-9149(83)80120-9","article-title":"Effect of intravenous and intracoronary nifedipine on coronary blood flow and myocardial oxygen consumption","volume":"51","author":"Schanzenbacher","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB200","series-title":"Presented at the 5th International Symposium on calcium antagonists","article-title":"Precipitous fall in blood pressure in the treatment of chronic hypertension","author":"Wilson","year":"1991"},{"key":"10.1016\/j.pcad.2004.04.006_BIB201","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/01.CIR.92.5.1068","article-title":"Nifedipine and mortality. Grave defects in the dossier","volume":"92","author":"Opie","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2004.04.006_BIB202","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/jama.1995.03530080036038","article-title":"The risk of myocardial infarction associated with antihypertensive drug therapies","volume":"274","author":"Psaty","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2004.04.006_BIB203","series-title":"New analyses regarding the safety of calcium channel blockers","year":"1995"},{"key":"10.1016\/j.pcad.2004.04.006_BIB204","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0895-7061(95)00416-5","article-title":"Calcium antagonists and cardiovascular prognosis","volume":"9","author":"Laragh","year":"1996","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB205","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0002-9149(98)00496-2","article-title":"Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival Evaluation","volume":"82","author":"O\u2019Connor","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB206","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/oxfordjournals.eurheartj.a015115","article-title":"Doppler flow and echocardiography in functional cardiac insufficiency: assessment of nisoldipine therapy. Results of the DEFIANT-II Study","volume":"18","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2004.04.006_BIB207","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/oxfordjournals.eurheartj.a014695","article-title":"Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS)","volume":"17","author":"Rehnqvist","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2004.04.006_BIB208","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0735-1097(96)00109-X","article-title":"Calcium antagonists and mortality in patients with coronary artery disease","volume":"28","author":"Braun","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB209","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/j.1875-9114.1996.tb02963.x","article-title":"The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension","volume":"16","author":"Jick","year":"1996","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pcad.2004.04.006_BIB210","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00001648-199707000-00017","article-title":"Antihypertensive drugs and fatal myocardial infarction in persons with uncomplicated hypertension","volume":"8","author":"Jick","year":"1997","journal-title":"Epidemiology"},{"key":"10.1016\/j.pcad.2004.04.006_BIB211","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/08037059509077588","article-title":"Association between various drugs used for hypertension and risk of acute myocardial infarction","volume":"4","author":"Aursnes","year":"1995","journal-title":"Blood Press"},{"key":"10.1016\/j.pcad.2004.04.006_BIB212","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/oxfordjournals.eurheartj.a014668","article-title":"Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina","volume":"17","author":"Dargie","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2004.04.006_BIB213","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0033-0620(96)80015-6","article-title":"Calcium channel antagonists in the management of anginal syndromes","volume":"38","author":"Opie","year":"1996","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2004.04.006_BIB214","series-title":"Coronary artery spasm","year":"1983"},{"key":"10.1016\/j.pcad.2004.04.006_BIB215","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/0002-8703(89)90842-9","article-title":"Efficacy and safety of amlodipine in vasospastic angina","volume":"118","author":"Chahine","year":"1989","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2004.04.006_BIB216","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0002-9149(87)90787-9","article-title":"Efficacy of sustained-release verapamil in chronic stable angina pectoris","volume":"59","author":"Weiner","year":"1987","journal-title":"Am J Cardiol"},{"issue":"Suppl 3","key":"10.1016\/j.pcad.2004.04.006_BIB217","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/BF00877860","article-title":"Primary prevention in patients with coronary heart disease","volume":"9","author":"Rehnqvist","year":"1995","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pcad.2004.04.006_BIB218","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/bmj.299.6709.1187","article-title":"Calcium channel blockers in acute myocardial infarction and unstable angina","volume":"299","author":"Held","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.pcad.2004.04.006_BIB219","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9149(90)90351-Z","article-title":"Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II\u2014DAVIT II)","volume":"66","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB220","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/0002-9149(91)90944-G","article-title":"Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies","volume":"67","author":"Yusuf","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB221","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0002-9149(93)91069-T","article-title":"Are all calcium antagonists equally effective for reducing reinfarction rate?","volume":"72","author":"Messerli","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB222","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0002-9149(97)89365-4","article-title":"A controlled trial of verapamil in patients after acute myocardial infarction","volume":"77","author":"Rengo","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB223","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM198608143150704","article-title":"Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial","volume":"315","author":"Gibson","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB224","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM198808183190701","article-title":"The effect of diltiazem on mortality and reinfarction after myocardial infarction","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB225","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0002-9149(96)00860-0","article-title":"Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone","volume":"79","author":"Fischer-Hansen","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB226","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0002-9149(91)90773-E","article-title":"Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension","volume":"68","author":"Moss","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB227","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/oxfordjournals.eurheartj.a060486","article-title":"The prognostic significance of post-infarction angina pectoris and the effect of verapamil on the incidence of angina pectoris and prognosis","volume":"15","author":"Jespersen","year":"1994","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2004.04.006_BIB228","article-title":"Does exercise-induced ST-segment depression predict benefit of medical intervention in patients recovering from acute myocardial infarction?","volume":"233","author":"Jespersen","year":"1993","journal-title":"J Intern Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB229","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/00004872-199508001-00009","article-title":"Update on the use of angiotensin converting enzyme inhibitors and calcium antagonists in postinfarction patients","volume":"13","author":"Persson","year":"1995","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB230","doi-asserted-by":"crossref","first-page":"153B","DOI":"10.1016\/0002-9149(87)90096-8","article-title":"Use of calcium antagonists for cardiac arrhythmias","volume":"59","author":"Singh","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB231","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/01.RES.52.3.302","article-title":"Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil, and nifedipine compared","volume":"52","author":"Nakaya","year":"1983","journal-title":"Circ Res"},{"key":"10.1016\/j.pcad.2004.04.006_BIB232","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0002-9149(97)00722-4","article-title":"Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure","volume":"80","author":"Grossman","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB233","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/00005344-198611000-00022","article-title":"Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin-angiotensin-aldosterone system in hypertensive patients","volume":"8","author":"Leonetti","year":"1986","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB234","series-title":"Cardiovascular Drug Therapy","first-page":"908","article-title":"Cardiac effects of calcium antagonists in hypertension","author":"Messerli","year":"1996"},{"key":"10.1016\/j.pcad.2004.04.006_BIB235","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJM198210073071516","article-title":"Conduction abnormalities due to diltiazem [letter]","volume":"307","author":"Hossack","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB236","doi-asserted-by":"crossref","first-page":"24B","DOI":"10.1016\/0002-9149(87)90078-6","article-title":"Differences in cardiovascular profile among calcium antagonists","volume":"59","author":"Taira","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB237","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0735-1097(97)00095-8","article-title":"Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine","volume":"29","author":"Wenzel","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB238","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s002280050362","article-title":"Amlodipine lowers blood pressure without increasing sympathetic activity or activating the renin-angiotensin system in patients with essential hypertension","volume":"53","author":"Sasaguri","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB239","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1440-1681.1998.tb02254.x","article-title":"Effects of amlodipine and nifedipine retard on autonomic nerve activity in hypertensive patients","volume":"25","author":"Minami","year":"1998","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB240","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000013264.41234.24","article-title":"Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension","volume":"39","author":"Binggeli","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2004.04.006_BIB241","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-8703(97)70101-7","article-title":"Effect of amlodipine on norepinephrine kinetics and baroreflex function in patients with congestive heart failure","volume":"134","author":"Goldsmith","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2004.04.006_BIB242","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0002-9149(93)90354-F","article-title":"Disparate cardiovascular response to stress tests during isradipine and fosinopril therapy","volume":"72","author":"Grossman","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2004.04.006_BIB243","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/ajkd.2000.16225","article-title":"Preserving renal function in adults with hypertension and diabetes","volume":"36","author":"Bakris","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pcad.2004.04.006_BIB244","doi-asserted-by":"crossref","first-page":"305S","DOI":"10.1093\/ajh\/3.10.305","article-title":"Renal vascular effects of calcium channel blockers in hypertension","volume":"3","author":"Benstein","year":"1990","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB245","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0272-6386(93)70120-N","article-title":"Calcium antagonists and the kidney","volume":"21","author":"Epstein","year":"1993","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 6","key":"10.1016\/j.pcad.2004.04.006_BIB246","first-page":"S21","article-title":"Lipophilic dihydropyridines provide renal protection from cyclosporin toxicity","volume":"11","author":"Rodicio","year":"1993","journal-title":"J Hypertens"},{"issue":"Suppl","key":"10.1016\/j.pcad.2004.04.006_BIB247","doi-asserted-by":"crossref","first-page":"173S","DOI":"10.1093\/ajh\/2.6.173S","article-title":"Do calcium antagonists protect the human hypertensive kidney?","volume":"2","author":"Bauer","year":"1989","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB248","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/BF02125735","article-title":"The calcium channel blocker nisoldipine delays progression of chronic renal failure in humans (preliminary communication)","volume":"1","author":"Eliahou","year":"1988","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.pcad.2004.04.006_BIB249","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2004.04.006_BIB250","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1001\/archinte.1991.00400120007001","article-title":"Calcium antagonists and diabetic nephropathy","volume":"151","author":"Epstein","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB251","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/ki.1993.114","article-title":"Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms","volume":"43","author":"Dworkin","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.pcad.2004.04.006_BIB252","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB253","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.1994.03510280037029","article-title":"Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria","volume":"271","author":"Viberti","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2004.04.006_BIB254","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/bmj.302.6770.210","article-title":"Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria","volume":"302","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.pcad.2004.04.006_BIB255","doi-asserted-by":"crossref","first-page":"707","DOI":"10.7326\/0003-4819-112-9-707","article-title":"Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus","volume":"112","author":"Bakris","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB256","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/00004872-198811000-00011","article-title":"Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy","volume":"6","author":"Mimran","year":"1988","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB257","doi-asserted-by":"crossref","first-page":"987","DOI":"10.7326\/0003-4819-113-12-987","article-title":"Effects of different calcium antagonists on proteinuria associated with diabetes mellitus","volume":"113","author":"Demarie","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB258","first-page":"333","article-title":"Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients","volume":"7","author":"O\u2019Donnell","year":"1993","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB259","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"for the Collaborative Study Group","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB260","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/ki.1992.139","article-title":"Treatment of arterial hypertension in diabetic humans","volume":"41","author":"Bakris","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.pcad.2004.04.006_BIB261","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/00004872-199610000-00013","article-title":"Shanghai trial of nifedipine in the elderly (STONE)","volume":"14","author":"Gong","year":"1996","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB262","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00004872-199816120-00016","article-title":"Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension","volume":"16","author":"Liu","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB263","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2004.04.006_BIB264","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.HYP.34.5.1129","article-title":"Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives","volume":"34","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2004.04.006_BIB265","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199903043400902","article-title":"Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension","volume":"340","author":"Tuomilehto","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB266","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1001\/archinte.160.16.2447","article-title":"High blood pressure and diabetes mellitus","volume":"160","author":"Grossman","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB267","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(00)03306-7","article-title":"Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies","volume":"356","author":"Pahor","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2004.04.006_BIB268","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(00)03307-9","article-title":"Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","volume":"356","author":"Neal","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2004.04.006_BIB269","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(01)06411-X","article-title":"Cardiovascular protection and blood pressure reduction","volume":"358","author":"Staessen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2004.04.006_BIB270","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"Effects of different blood-pressure-lowering regimens on major cardiovascular events","volume":"362","author":"Turnbull","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2004.04.006_BIB271","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2337\/diacare.21.4.597","article-title":"Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM","volume":"21","author":"Tatti","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcad.2004.04.006_BIB272","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1097\/00004872-200018110-00020","article-title":"Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients","volume":"18","author":"Lindholm","year":"2000","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB273","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199803053381003","article-title":"The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension","volume":"338","author":"Estacio","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB274","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/01.HYP.0000057420.27692.AD","article-title":"for INSIGHT","volume":"41","author":"Mancia","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2004.04.006_BIB275","doi-asserted-by":"crossref","first-page":"542","DOI":"10.7326\/0003-4819-138-7-200304010-00010","article-title":"Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy","volume":"138","author":"Berl","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB276","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amjmed.2003.07.015","article-title":"Are calcium antagonists beneficial in diabetic patients with hypertension?","volume":"116","author":"Grossman","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB277","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2004.04.006_BIB278","doi-asserted-by":"crossref","DOI":"10.1097\/00004872-200410000-00001","article-title":"Antihypertensive therapy and new onset diabetes","author":"Messerli","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB279","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00002018-199513030-00003","article-title":"Calcium antagonists. Drug interactions of clinical significance","volume":"13","author":"Rosenthal","year":"1995","journal-title":"Drug Saf"},{"key":"10.1016\/j.pcad.2004.04.006_BIB280","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1001\/archinte.1992.00400240115019","article-title":"Carbamazepine neurotoxic reaction after administration of diltiazem","volume":"152","author":"Maoz","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB281","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/0140-6736(91)92564-I","article-title":"Interaction of citrus juices with felodipine and nifedipine (Letter)","volume":"337","author":"Chayen","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2004.04.006_BIB282","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0895-7061(02)03000-5","article-title":"Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives","volume":"15","author":"Leonetti","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB283","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0895-7061(02)03087-X","article-title":"Pedal edema\u2014Not all dihydropyridine calcium antagonists are created equal (Editorial)","volume":"15","author":"Messerli","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB284","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0895-7061(03)01017-3","article-title":"beta-Blockers in hypertension\u2014The emperor has no clothes","volume":"16","author":"Messerli","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2004.04.006_BIB285","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM198808183190701","article-title":"The effect of diltiazem on mortality and reinfarction after myocardial infarction","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2004.04.006_BIB286","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0002-9149(96)00860-0","article-title":"Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone","volume":"79","author":"Hansen","year":"1997","journal-title":"Am J Cardiol"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062004000222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062004000222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T20:01:33Z","timestamp":1705953693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062004000222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":286,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0033062004000222"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2004.04.006","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}